adamantylamide-alanyl-isoglutamine has been researched along with Granuloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botros, S; Hassan, S; Ibrahim, A; Mahmoud, S; Masek, K; Zidek, Z | 1 |
1 other study(ies) available for adamantylamide-alanyl-isoglutamine and Granuloma
| Article | Year |
|---|---|
Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibody Formation; Antiplatyhelmintic Agents; Dipeptides; Drug Resistance; Granuloma; Immunity, Cellular; Liver; Lymphocytes; Mice; Mice, Inbred Strains; Praziquantel; Rats; Recurrence; Schistosomiasis mansoni; Schistosomicides | 1996 |